Breaking News Instant updates and real-time market news.

APH

Amphenol

$68.05 /

-0.21 (-0.31%)

, MTSC

MTS Systems

$58.50 /

+ (+0.00%)

11:04
04/07/21
04/07
11:04
04/07/21
11:04

Amphenol completes acquisition of MTS systems

Amphenol (APH) announced that it has completed its acquisition of MTS Systems (MTSC). In connection with the close of the transaction, MTS common stock will cease to trade on the NASDAQ. Amphenol expects the MTS Sensors business to add approximately $350M in sales in the first twelve months after closing. Amphenol plans to further discuss the MTS acquisition on its first quarter earnings call, scheduled for April 28.

APH

Amphenol

$68.05 /

-0.21 (-0.31%)

MTSC

MTS Systems

$58.50 /

+ (+0.00%)

  • 28

    Apr

APH Amphenol
$68.05 /

-0.21 (-0.31%)

01/19/21 Baird
Baird incrementally positive on ITW's MTS test & simulation business acquisition
12/29/20 JPMorgan
Amphenol reinstated with a Neutral at JPMorgan
10/19/20 Baird
Amphenol initiated with an Outperform at Baird
09/15/20 UBS
Amphenol initiated with a Buy at UBS
MTSC MTS Systems
$58.50 /

+ (+0.00%)

12/09/20 Colliers
MTS Systems downgraded to Neutral from Buy at Colliers
08/20/20 Colliers
MTS Systems initiated with a Buy at Colliers
04/17/20 Wells Fargo
MTS Systems downgraded to Underweight from Equal Weight at Wells Fargo
04/17/20 Wells Fargo
MTS Systems downgraded to Underweight from Equal Weight at Wells Fargo

TODAY'S FREE FLY STORIES

Hot Stocks
Profound Medical, Akumin enter in U.S. agreement for TULSA-PRO » 07:54
05/06/21
05/06
07:54
05/06/21
07:54
PROF

Profound Medical

$18.26 /

-0.04 (-0.22%)

, AKU

Akumin

$2.96 /

+0.01 (+0.34%)

Profound Medical (PROF)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PROF Profound Medical
$18.26 /

-0.04 (-0.22%)

AKU Akumin
$2.96 /

+0.01 (+0.34%)

PROF Profound Medical
$18.26 /

-0.04 (-0.22%)

03/03/21 Alliance Global Partners
Alliance Global still bullish on Profound Medical after 'mixed' Q4
01/25/21 Lake Street
Profound Medical price target raised to $32 from $27 at Lake Street
01/07/21 Alliance Global Partners
Profound Medical price target raised to $28.25 from $20.25 at Alliance Global
09/15/20 Jefferies
Profound Medical initiated with a Buy at Jefferies
AKU Akumin
$2.96 /

+0.01 (+0.34%)

09/03/20 Clarus
Akumin can re-rate as Nasdaq listing raises U.S. awareness, says Clarus
  • 16
    Jul
Earnings
Agenus reports Q1 EPS (27c), consensus (31c) » 07:54
05/06/21
05/06
07:54
05/06/21
07:54
AGEN

Agenus

$2.95 /

-0.025 (-0.84%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGEN Agenus
$2.95 /

-0.025 (-0.84%)

AGEN Agenus
$2.95 /

-0.025 (-0.84%)

04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
09/22/20 B. Riley FBR
B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
09/18/20 Jefferies
Agenus price target raised to $8 from $5 at Jefferies
AGEN Agenus
$2.95 /

-0.025 (-0.84%)

Hot Stocks
Luokung Technology announces favorable ruling granting preliminary injunction » 07:53
05/06/21
05/06
07:53
05/06/21
07:53
LKCO

Luokung Technology

$1.48 /

-0.14 (-8.64%)

Luokung Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LKCO Luokung Technology
$1.48 /

-0.14 (-8.64%)

LKCO Luokung Technology
$1.48 /

-0.14 (-8.64%)

Earnings
CarMax targets FY26 revenue $33B » 07:53
05/06/21
05/06
07:53
05/06/21
07:53
KMX

CarMax

$137.85 /

+0.535 (+0.39%)

Expects to grow national…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KMX CarMax
$137.85 /

+0.535 (+0.39%)

KMX CarMax
$137.85 /

+0.535 (+0.39%)

05/03/21 Evercore ISI
CarMax added to Tactical Outperform list at Evercore ISI
04/09/21 Oppenheimer
CarMax price target raised to $153 from $130 at Oppenheimer
04/05/21 Evercore ISI
CarMax pullback an attractive entry opportunity, says Evercore ISI
04/05/21 Stephens
CarMax price target raised to $154 from $130 at Stephens
KMX CarMax
$137.85 /

+0.535 (+0.39%)

KMX CarMax
$137.85 /

+0.535 (+0.39%)

KMX CarMax
$137.85 /

+0.535 (+0.39%)

Earnings
Adient reports Q1 adjusted EPS $1.13, consensus 56c » 07:53
05/06/21
05/06
07:53
05/06/21
07:53
ADNT

Adient

$46.99 /

+1.345 (+2.95%)

Reports Q1 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADNT Adient
$46.99 /

+1.345 (+2.95%)

ADNT Adient
$46.99 /

+1.345 (+2.95%)

03/25/21 Wells Fargo
Adient initiated with an Overweight at Wells Fargo
03/18/21
Fly Intel: Top five analyst downgrades
03/18/21 Morgan Stanley
Adient downgraded to Underweight on long-term industry risk at Morgan Stanley
03/17/21 Morgan Stanley
Adient downgraded to Underweight from Equal Weight at Morgan Stanley
ADNT Adient
$46.99 /

+1.345 (+2.95%)

ADNT Adient
$46.99 /

+1.345 (+2.95%)

ADNT Adient
$46.99 /

+1.345 (+2.95%)

Hot Stocks
Palantir announces extended commitment from U.S. Coast Guard » 07:52
05/06/21
05/06
07:52
05/06/21
07:52
PLTR

Palantir

$21.17 /

-0.46 (-2.13%)

Palantir Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLTR Palantir
$21.17 /

-0.46 (-2.13%)

PLTR Palantir
$21.17 /

-0.46 (-2.13%)

04/22/21 Wolfe Research
Palantir initiated with a Peer Perform at Wolfe Research
03/15/21 Credit Suisse
Palantir assumed with an Underperform at Credit Suisse
02/17/21
Fly Intel: Top five analyst upgrades
02/17/21 RBC Capital
Palantir price target raised to $27 from $15 at RBC Capital
PLTR Palantir
$21.17 /

-0.46 (-2.13%)

PLTR Palantir
$21.17 /

-0.46 (-2.13%)

PLTR Palantir
$21.17 /

-0.46 (-2.13%)

PLTR Palantir
$21.17 /

-0.46 (-2.13%)

Earnings
Protara Therapeutics reports Q1 EPS ($1.20), consensus (73c) » 07:52
05/06/21
05/06
07:52
05/06/21
07:52
TARA

Protara Therapeutics

$10.30 /

-0.08 (-0.77%)

"We remain on track…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TARA Protara Therapeutics
$10.30 /

-0.08 (-0.77%)

TARA Protara Therapeutics
$10.30 /

-0.08 (-0.77%)

04/26/21 Oppenheimer
Protara Therapeutics price target lowered to $32 from $43 at Oppenheimer
10/19/20 Cowen
Protara Therapeutics initiated with an Outperform at Cowen
07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Guggenheim
Protara Therapeutics started with Buy rating, $50 target at Guggenheim
TARA Protara Therapeutics
$10.30 /

-0.08 (-0.77%)

  • 22
    Sep
TARA Protara Therapeutics
$10.30 /

-0.08 (-0.77%)

Hot Stocks
Mogo in partnership with Tom Lee's Fundstrat for crypto research » 07:52
05/06/21
05/06
07:52
05/06/21
07:52
MOGO

Mogo

$8.16 /

-0.02 (-0.24%)

Mogo announced a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOGO Mogo
$8.16 /

-0.02 (-0.24%)

MOGO Mogo
$8.16 /

-0.02 (-0.24%)

03/24/21 Canaccord
Mogo price target raised to C$14 from C$13 at Canaccord
03/23/21 H.C. Wainwright
Outlook, Moka deal should 'drive excitement' about Mogo, says H.C. Wainwright
03/01/21 H.C. Wainwright
Mogo price target raised to $16 from $4 at H.C. Wainwright
02/11/21 Canaccord
Mogo downgraded to Hold from Speculative Buy at Canaccord
MOGO Mogo
$8.16 /

-0.02 (-0.24%)

Upgrade
Jefferies upgrades Mercury Systems, sees growth intact despite disappointing Q3 » 07:51
05/06/21
05/06
07:51
05/06/21
07:51
MRCY

Mercury Systems

$57.72 /

-12.47 (-17.77%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRCY Mercury Systems
$57.72 /

-12.47 (-17.77%)

MRCY Mercury Systems
$57.72 /

-12.47 (-17.77%)

05:11 Today Jefferies
Mercury Systems upgraded to Buy from Hold at Jefferies
05/05/21
Fly Intel: Top five analyst downgrades
05/05/21 Canaccord
Canaccord downgrades Mercury Systems on lower growth outlook
05/05/21 Canaccord
Mercury Systems downgraded to Hold from Buy at Canaccord
MRCY Mercury Systems
$57.72 /

-12.47 (-17.77%)

MRCY Mercury Systems
$57.72 /

-12.47 (-17.77%)

Hot Stocks
Adaptimmune expects cash to fund operations into early 2023 » 07:51
05/06/21
05/06
07:51
05/06/21
07:51
ADAP

Adaptimmune

$5.11 /

-0.22 (-4.13%)

The Company believes that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

  • 02
    Jun
Earnings
CECO Environmental reports Q1 adjusted EPS 9c, consensus 9c » 07:51
05/06/21
05/06
07:51
05/06/21
07:51
CECE

CECO Environmental

$7.47 /

+0.08 (+1.08%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CECE CECO Environmental
$7.47 /

+0.08 (+1.08%)

CECE CECO Environmental
$7.47 /

+0.08 (+1.08%)

03/04/21 H.C. Wainwright
CECO Environmental price target raised to $15 from $9 at H.C. Wainwright
Earnings
Adaptimmune reports Q1 EPS (4c), consensus (25c) » 07:51
05/06/21
05/06
07:51
05/06/21
07:51
ADAP

Adaptimmune

$5.11 /

-0.22 (-4.13%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

  • 02
    Jun
Earnings
Laureate Education reaffirms FY21 revenue $1B-$1.04B, two estimates $1B » 07:50
05/06/21
05/06
07:50
05/06/21
07:50
LAUR

Laureate Education

$13.37 /

-0.16 (-1.18%)

Sees FY21 total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

09/15/20 Barclays
Laureate Education price target raised to $14 from $11 at Barclays
09/11/20 Stifel
Laureate Education's Walden sale proceeds less than expected, says Stifel
06/24/20 Morgan Stanley
Laureate Education upgraded to Overweight from Equal Weight at Morgan Stanley
05/11/20 BMO Capital
Laureate Education price target lowered to $16 from $21 at BMO Capital
LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

Hot Stocks
EQT Corporation to acquire membership interests in Alta subsidiaries for $2.93B » 07:50
05/06/21
05/06
07:50
05/06/21
07:50
EQT

EQT Corporation

$20.19 /

+0.28 (+1.41%)

EQT Corporation announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EQT EQT Corporation
$20.19 /

+0.28 (+1.41%)

EQT EQT Corporation
$20.19 /

+0.28 (+1.41%)

03/23/21 Goldman Sachs
EQT Corporation assumed with a Buy at Goldman Sachs
03/15/21 Piper Sandler
EQT Corporation price target raised to $22 from $18 at Piper Sandler
02/18/21 TD Securities
EQT Corporation price target raised to $24 from $20 at TD Securities
01/11/21 Mizuho
EQT Corporation price target lowered to $19 from $28 at Mizuho
EQT EQT Corporation
$20.19 /

+0.28 (+1.41%)

  • 28
    Oct
EQT EQT Corporation
$20.19 /

+0.28 (+1.41%)

Earnings
Black Knight raises FY21 adjusted EPS view to $2.16-$2.24 from $2.11-$2.22 » 07:49
05/06/21
05/06
07:49
05/06/21
07:49
BKI

Black Knight

$71.42 /

-1.73 (-2.37%)

FY21 consensus $2.20.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKI Black Knight
$71.42 /

-1.73 (-2.37%)

BKI Black Knight
$71.42 /

-1.73 (-2.37%)

04/19/21 Barclays
Black Knight shares nearing 'conviction buy levels,' says Barclays
04/13/21
Fly Intel: Top five analyst initiations
04/13/21 Raymond James
Black Knight initiated with a Market Perform at Raymond James
02/17/21 Susquehanna
Susquehanna upgrades Black Knight to Positive as growth resumes
BKI Black Knight
$71.42 /

-1.73 (-2.37%)

  • 17
    Jun
Earnings
Ranpak Holdings reports Q1 EPS 8c, consensus (2c) » 07:49
05/06/21
05/06
07:49
05/06/21
07:49
PACK

Ranpak Holdings

$20.13 /

+0.445 (+2.26%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PACK Ranpak Holdings
$20.13 /

+0.445 (+2.26%)

PACK Ranpak Holdings
$20.13 /

+0.445 (+2.26%)

04/26/21 Berenberg
Ranpak Holdings initiated with a Buy at Berenberg
04/19/21 Sidoti
Ranpak Holdings initiated with a Buy at Sidoti
PACK Ranpak Holdings
$20.13 /

+0.445 (+2.26%)

Earnings
Brookfield Infrastructure Partners reports Q1 FFO 93c, consensus 87c » 07:49
05/06/21
05/06
07:49
05/06/21
07:49
BIP

Brookfield Infrastructure Partners

$53.31 /

+0.36 (+0.68%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIP Brookfield Infrastructure Partners
$53.31 /

+0.36 (+0.68%)

BIP Brookfield Infrastructure Partners
$53.31 /

+0.36 (+0.68%)

02/11/21 Credit Suisse
Inter Pipeline upgraded to Neutral from Underperform at Credit Suisse
02/11/21 CIBC
Inter Pipeline upgraded to Outperformer from Neutral at CIBC
02/09/21 Barclays
Brookfield Infrastructure Partners price target raised to C$73 at Barclays
01/06/21 Wells Fargo
Brookfield Infrastructure downgraded to Equal Weight from Overweight at Wells Fargo
BIP Brookfield Infrastructure Partners
$53.31 /

+0.36 (+0.68%)

Earnings
Laureate Education reaffirms FY22 revenue 1.080B, two estimates $993.18M » 07:48
05/06/21
05/06
07:48
05/06/21
07:48
LAUR

Laureate Education

$13.37 /

-0.16 (-1.18%)

Sees FY21 total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

09/15/20 Barclays
Laureate Education price target raised to $14 from $11 at Barclays
09/11/20 Stifel
Laureate Education's Walden sale proceeds less than expected, says Stifel
06/24/20 Morgan Stanley
Laureate Education upgraded to Overweight from Equal Weight at Morgan Stanley
05/11/20 BMO Capital
Laureate Education price target lowered to $16 from $21 at BMO Capital
LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

Hot Stocks
Intellia Therapeutics expects cash to fund requirements through next 24 months » 07:48
05/06/21
05/06
07:48
05/06/21
07:48
NTLA

Intellia Therapeutics

$71.38 /

-0.64 (-0.89%)

Intellia expects that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

05/03/21 RBC Capital
Intellia Therapeutics initiated with an Outperform at RBC Capital
03/04/21 JMP Securities
Intellia Therapeutics initiated with an Outperform at JMP Securities
02/26/21 Truist
Intellia Therapeutics price target raised to $80 from $40 at Truist
02/10/21 Chardan
Intellia Therapeutics price target raised to $85 from $57.50 at Chardan
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

  • 02
    Dec
  • 03
    Jun
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

Recommendations
Medallion Financial price target raised to $12 from $11 at B. Riley » 07:48
05/06/21
05/06
07:48
05/06/21
07:48
MFIN

Medallion Financial

/

+

B. Riley analyst Steve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MFIN Medallion Financial
/

+

MFIN Medallion Financial
/

+

04/07/21 B. Riley
Medallion Financial price target raised to $11 from $10 at B. Riley
02/19/21 B. Riley Securities
Medallion Financial price target raised to $10 from $8 at B. Riley Securities
11/24/20 B. Riley Securities
Medallion Financial resumed with a Buy at B. Riley Securities
MFIN Medallion Financial
/

+

Recommendations
SunPower price target lowered to $24 from $40 at Roth Capital » 07:48
05/06/21
05/06
07:48
05/06/21
07:48
SPWR

SunPower

$23.28 /

+0.29 (+1.26%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPWR SunPower
$23.28 /

+0.29 (+1.26%)

SPWR SunPower
$23.28 /

+0.29 (+1.26%)

06:49 Today Barclays
SunPower price target lowered to $20 from $23 at Barclays
04/22/21 Barclays
SunPower price target lowered to $23 from $28 at Barclays
03/22/21 Goldman Sachs
SunPower downgraded to Neutral from Buy at Goldman Sachs
03/16/21 Morgan Stanley
Morgan Stanley says proposed California rules 'skew negative' for rooftop solar
SPWR SunPower
$23.28 /

+0.29 (+1.26%)

SPWR SunPower
$23.28 /

+0.29 (+1.26%)

SPWR SunPower
$23.28 /

+0.29 (+1.26%)

SPWR SunPower
$23.28 /

+0.29 (+1.26%)

Hot Stocks
Intellia Therapeutics announces anticipated milestones for 2021 » 07:48
05/06/21
05/06
07:48
05/06/21
07:48
NTLA

Intellia Therapeutics

$71.38 /

-0.64 (-0.89%)

The Company has set forth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

05/03/21 RBC Capital
Intellia Therapeutics initiated with an Outperform at RBC Capital
03/04/21 JMP Securities
Intellia Therapeutics initiated with an Outperform at JMP Securities
02/26/21 Truist
Intellia Therapeutics price target raised to $80 from $40 at Truist
02/10/21 Chardan
Intellia Therapeutics price target raised to $85 from $57.50 at Chardan
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

  • 02
    Dec
  • 03
    Jun
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

Earnings
Xoma reports Q1 EPS (70c), consensus (16c) » 07:47
05/06/21
05/06
07:47
05/06/21
07:47
XOMA

Xoma

$34.24 /

-2.11 (-5.80%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XOMA Xoma
$34.24 /

-2.11 (-5.80%)

XOMA Xoma
$34.24 /

-2.11 (-5.80%)

01/19/21 H.C. Wainwright
Xoma price target raised to $56 from $30 at H.C. Wainwright
XOMA Xoma
$34.24 /

-2.11 (-5.80%)

Earnings
Intellia Therapeutics reports Q1 EPS (69c), consensus (66c) » 07:47
05/06/21
05/06
07:47
05/06/21
07:47
NTLA

Intellia Therapeutics

$71.38 /

-0.64 (-0.89%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

05/03/21 RBC Capital
Intellia Therapeutics initiated with an Outperform at RBC Capital
03/04/21 JMP Securities
Intellia Therapeutics initiated with an Outperform at JMP Securities
02/26/21 Truist
Intellia Therapeutics price target raised to $80 from $40 at Truist
02/10/21 Chardan
Intellia Therapeutics price target raised to $85 from $57.50 at Chardan
  • 02
    Dec
  • 03
    Jun
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

Recommendations
Avid Technology price target raised to $30 from $25 at B. Riley » 07:47
05/06/21
05/06
07:47
05/06/21
07:47
AVID

Avid Technology

$21.75 /

-0.95 (-4.19%)

B. Riley analyst Josh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVID Avid Technology
$21.75 /

-0.95 (-4.19%)

AVID Avid Technology
$21.75 /

-0.95 (-4.19%)

03/17/21 RBC Capital
Avid Technology initiated with an Outperform at RBC Capital
03/10/21 B. Riley Securities
Avid Technology price target raised to $25 from $24 at B.Riley Securities
03/03/21 B. Riley Securities
Avid Technology price target raised to $24 from $18 at B. Riley Securities
02/09/21 Northland
Avid Technology price target raised to $32 from $22 at Northland
AVID Avid Technology
$21.75 /

-0.95 (-4.19%)

AVID Avid Technology
$21.75 /

-0.95 (-4.19%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.